Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Journal of Neuroimmunology|November 26, 2013
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanismLucia Lisi, Antonella Tramutola, Pierluigi Navarra, et al.
Biochemical Pharmacology|July 26, 2020
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, et al.
Journal of Neuroinflammation|January 7, 2011
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytesLucia Lisi, Pierluigi Navarra, Douglas L Feinstein, et al.
Glia|October 10, 2012
mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosisCinzia Dello Russo, Lucia Lisi, Douglas L Feinstein, et al.
Medical Archives (Sarajevo, Bosnia and Herzegovina)|February 9, 2018
The Trabecular Bone Score Predicts Spine Fragility Fractures in Postmenopausal Caucasian Women Without Osteoporosis Independently of Bone Mineral DensityClaudio Ripamonti, Lucia Lisi, Angela Buffa, et al.
Brain Sciences|May 18, 2019
Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell LineMarta Chiavari, Gabriella Maria Pia Ciotti, Pierluigi Navarra, et al.
Brain Sciences|June 26, 2026
Retinal Pigment Epithelium Cell Line ARPE-19 Exposed to M1 Microglia Releases Proinflammatory Cytokines and Reactive Oxygen Species Through MAP-Kinase PathwayMichela Pizzoferrato, Benedetto Falsini, Giuseppe Tringali, et al.
Journal of Neurochemistry|April 12, 2017
Interactions between integrase inhibitors and human arginase 1Lucia Lisi, Michela Pizzoferrato, Fabiola Teresa Miscioscia, et al.
Peptides|March 26, 2014
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitroMaria Cristina Greco, Lucia Lisi, Diego Currò, et al.
Pharmacological Research|November 26, 2021
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironmentLucia Lisi, Pedro Miguel Lacal, Maria Martire, et al.
Pageof 9